Market Vectors Pharmaceutical ETF (PPH)

Add to Watchlists Create an Alert
61.20 +0.25  +0.41% NYSE Arca Aug 19, 8:00PM BATS Real time Currency in USD
View Full Chart
PPH Price Chart

PPH Description

Market Vectors Pharmaceutical ETF is a long only equity fund managed by Market Vectors that tracks the MV US Listed Pharmaceutical 25 NR USD index and has 378.86M USD assets under management. It has an expected distribution yield of 0.80%, a Prospective PE Ratio of 21.37, and a Prospective Price to Book Value of 3.344. The fund has a net expense ratio of 0.35%, turns over its positions 3.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: MV US Listed Pharmaceutical 25 NR USD

PPH Key Info

Expense Ratio (2-1-14) 0.35%
Assets Under Management (8-19-14) 378.86M
30-Day Average Volume (8-19-14) 124903.1
Net Asset Value (8-19-14) 61.22
Discount or Premium to NAV (8-19-14) -0.03%
Turnover Ratio (9-30-13) 3.00%

PPH Asset Allocation

Type % Net % Long % Short
Cash 0.11% 0.11% 0.00%
Stock 100.0% 100.0% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.15% 0.03% 0.18%
As of Aug. 18, 2014

PPH Region Exposure

Americas 57.15%
North America 57.15%
Latin America 0.00%
Greater Europe 42.85%
United Kingdom 12.56%
Europe Developed 25.91%
Europe Emerging 0.00%
Africa/Middle East 4.38%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Aug. 18, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Aug. 18, 2014

PPH Stock Market Capitalization

Giant 76.19%
Large 21.29%
Medium 2.56%
Small 0.00%
Micro 0.00%
As of Aug. 18, 2014
View More Holdings

PPH Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 10.54% 102.96 +0.25%
Novartis AG ADR 9.65% 88.63 +1.29%
Pfizer Inc 7.04% 28.94 +0.35%
Merck & Co Inc 5.71% 58.91 +0.84%
Sanofi ADR 5.22% 52.70 -1.11%
Novo Nordisk A/S ADR 4.90% 45.24 +0.42%
Bristol-Myers Squibb Company 4.63% 50.30 +0.62%
Abbott Laboratories 4.59% 42.54 +0.73%
Eli Lilly and Co 4.48% 62.16 +1.32%
Actavis PLC 4.47% 223.08 +2.30%
As of Aug. 18, 2014
Get Quote for
Advertisement

PPH Risk Info

Beta --
Max Drawdown (12-20-11 to 8-19-14) 7.95%
30 Day Average Volatility 11.80%

PPH Fundamentals

Distribution Yield TTM (8-19-14) 0.80%
Distribution Yield (Prospective) 2.16%
PE Ratio (Prospective) 21.37
PS Ratio (Prospective) 2.719
Price to Book Value (Prospective) 3.344
ROE 22.31%
ROA 8.96%
Number of Holdings 25.00
As of Aug. 18, 2014

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 8.37%
Forecasted Book Value Growth 6.44%
Forecasted Cash Flow Growth -2.54%
Forecasted Earnings Growth -0.32%
Forecasted Revenue Growth 3.01%
As of Aug. 18, 2014

PPH Performance

  Returns Total Returns
1M -1.31% -1.31%
3M 3.22% 3.65%
6M 5.90% 7.07%
1Y 29.06% 31.48%
3Y -- --
5Y -- --
As of Aug. 19, 2014

PPH Flows

1M -61.12M
3M -66.85M
6M -32.17M
YTD -23.86M
1Y -26.15M
3Y --
5Y --
As of July 31, 2014
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.